Bristol-Myers Squibb Company Profile >Global 500 > # 301
Global 500

Bristol-Myers Squibb

RANK
301
Previous: 300
Next: 302
F500-2020-115-Bristol-Myers-Squibb
Regis Duvignau—Reuters

Company Information

As of 2/1/2023
Country
U.S.
Headquarters
New York City
Industry
Pharmaceuticals
CEO
Giovanni Caforio
Website
www.bms.com
Company Type
Public
Ticker
BMY
Revenues ($M)
$46,738
Profits ($M)
$6,677
Market Value ($M)
$157,655
Employees
32,200
Figures are for the latest twelve months ended Sept. 30, 2022. Market value as of Jan. 20, 2023. Sources: Bloomberg; S&P Global.

Key Financials (Last Fiscal Year)
As of 8/3/2022

($ Millions)
% change
Revenues ($M)
$46,385
9.1%
Profits ($M)
$6,994
-
Assets ($M)
$109,314
-
Total Stockholder Equity ($M)
$35,946
-

Profit Ratios
As of 8/3/2022

Profit as % of Revenues
15.1%
Profits as % of Assets
6.4%
Profits as % of Stockholder Equity
19.5%

Bristol-Myers Squibb Rank History

Historical Data

YearRevenues ($M)Profits ($M)Assets ($M)Total Stockholder Equity ($M)
2021$42,51862.6%$-9,015-362.1%$118,481$37,822
2020$26,14515.9%$3,439-30.1%$129,944$51,598
FortuneDataStore ad
Lists ranking Bristol-Myers Squibb
RANK100000
World's Most Admired Companies - 2023The 25th Fortune World’s Most Admired Companies li...READ MORE
RANK82
Fortune 500 - 2022This year’s Fortune 500 marks the 68th running of ...READ MORE
RANK301
Global 500 - 2022Aggregate sales hit $37.8 trillion last year—an in...READ MORE
RANK23
Fortune Modern Board 25 - 2022Fortune collaborated with the Diligent Institute t...READ MORE
Latest news for Bristol-Myers Squibb